David H. Peyton
Corporate Officer/Principal bij Portland State University
Profiel
David H.
Peyton is the founder of DesignMedix, Inc. He is currently a Professor at Portland State University since 1987.
He completed his undergraduate degree at Abilene Christian University and his doctorate at the University of California, Santa Barbara.
Actieve functies van David H. Peyton
| Bedrijven | Functie | Begin |
|---|---|---|
| Portland State University | Corporate Officer/Principal | 30-10-2009 |
Eerdere bekende functies van David H. Peyton
| Bedrijven | Functie | Einde |
|---|---|---|
DesignMedix, Inc.
 DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Oprichter | - |
Opleiding van David H. Peyton
| Abilene Christian University | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
DesignMedix, Inc.
DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Health Technology |
